115 studies (23 from unattributed sources) on BPC-157 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Independent certificate-of-analysis evidence from third-party labs — the data behind the studies. Updated as new COAs are verified. Read the full grey-market analysis →
| Manufacturer | Batches | Avg purity | |
|---|---|---|---|
| Uther Peptide | 41 | 99.69% | View COA → |
| Unknown vendor (review) | 34 | 99.27% | View COA → |
| Verified Peptides | 32 | 99.46% | View COA → |
| Peptaris | 32 | 99.33% | View COA → |
| Qing Li Peptide | 32 | 97.1% | View COA → |
| Simple Peptide | 26 | 99.15% | View COA → |
| Hk Peptides | 23 | 99.64% | View COA → |
| (unknown) | 23 | 99.58% | View COA → |
Recent certificates: #63636 (97.701%) · #31775 (99.19%) · #56470 (99.22%) · #24273 (99.19%) · #26661 (99.53%) · #27705 (99.53%)
Manufacturers with published third-party certificates of analysis for BPC-157. Open a vendor to see every batch we've verified.
**BPC 157's profound ability to rapidly restore vascular integrity and organ function after severe systemic trauma, such as unilateral adrenalectomy, suggests broad utility in acute injury and circulatory compromise.*…
This harmonized `LC-HRMS` workflow significantly advances **doping control capabilities**, offering a more efficient and cost-effective approach. The superior stability of many compounds, including key peptides like *…
BPC-157 and its novel hybrid analogs, CIARA-1 and CIARA-2, competitively inhibit `Acetylcholinesterase (AChE)` in vitro, with CIARA-1 demonstrating the highest potency (Ki = **0.24 mM**).
This review highlights that **peptide therapies could offer a crucial adjunctive strategy for managing persistent symptoms in autoimmune thyroid disorders like Hashimoto's thyroiditis**, moving beyond mere hormone rep…
**Regenerative medicine offers a transformative outlook for individuals suffering from severe craniofacial and corneal neuropathic pain that has proven refractory to conventional treatments.** This review suggests a f…
This review underscores that despite extensive preclinical promise, **BPC-157** remains far from a clinically validated therapeutic. For peptide users and biohackers, this means current **BPC-157** preparations are la…
This comprehensive review underscores that current **BPC-157** use by biohackers and clinicians operates without validated protocols, approved formulations, or robust safety data. The identified `pharmacokinetic-pharm…
These findings significantly bolster the evidence for **BPC 157 as a potent therapeutic agent for acute ischemia-reperfusion injury**, particularly in skeletal muscle. The ability of BPC 157 to simultaneously modulate…
This study provides the first direct evidence of BPC 157's endothelium-dependent vasorelaxant effects in human arterial tissue, a significant step beyond animal models. For peptide users and biohackers, this suggests …
If proven feasible and effective, the use of mesna solution could significantly simplify and improve the safety of Endoscopic Submucosal Dissection (ESD) for superficial oesophageal squamous neoplasms (SOSNs). This in…
This comprehensive review underscores the significant therapeutic potential of BPC 157 as a broad-spectrum regenerative agent for complex musculoskeletal injuries. Its unique cytoprotective mechanism, which includes s…
This research provides critical tools for anti-doping laboratories to predict and identify peptide metabolites, significantly improving detection windows for prohibited substances. By understanding the metabolic fate …
This research provides critical insights into the in vitro metabolic pathways of synthetic doping peptides, which is essential for developing robust and sensitive anti-doping tests. The identification of liver S9 frac…
This study powerfully demonstrates BPC 157's potential as a broad-spectrum cardioprotective agent against drug-induced QTc prolongation. Given the wide array of medications that can cause this adverse effect, BPC 157 …
These compelling findings highlight BPC 157's significant therapeutic potential in treating severe gastrointestinal pathologies by promoting healing, reducing inflammation, and combating oxidative stress. Its ability …
This study provides compelling evidence that BPC 157 possesses significant anti-thrombotic and pro-angiogenic properties, making it a promising candidate for treating vascular disorders. The ability of BPC 157 to both…
This study provides compelling evidence that BPC 157 could represent a novel and highly effective therapeutic agent for combating Nosemosis in honeybees. The significant reduction in parasite load and improvement in c…
This study provides compelling evidence for the potent regenerative and cytoprotective effects of BPC 157, particularly its ability to promote vascular recruitment and accelerate gastrointestinal healing. The observed…
This comprehensive review unequivocally highlights BPC-157's broad therapeutic potential as a potent pro-angiogenic and regenerative agent. Its remarkable ability to promote and accelerate healing across such diverse …
This study demonstrates a novel and effective strategy for targeted delivery of therapeutic peptides using engineered probiotics, potentially enhancing their efficacy in treating gut-related inflammatory conditions. T…
This research highlights BPC 157's potent ability to protect the gastrointestinal tract from severe alcohol-induced injury, suggesting it could be a valuable therapeutic agent. Its mechanism, involving the nitric oxid…
These results underscore the significant therapeutic potential of BPC 157 for severe gastrointestinal injuries, particularly those involving perforation and the risk of peritonitis and sepsis. The ability of BPC 157 t…
This study powerfully demonstrates BPC 157's potent hepatoprotective, anti-inflammatory, and regenerative properties within a severe and clinically relevant model of liver injury. The ability of BPC 157 to significant…
This research highlights that BPC 157 possesses potent regenerative properties that could dramatically improve outcomes for musculoskeletal injuries. Its ability to accelerate healing, enhance tissue strength, and red…
This comprehensive review solidifies BPC 157's potential as a broad-spectrum therapeutic agent due to its consistent protective and reparative actions across diverse pathologies and organ systems. By linking its effec…
This research highlights the significant therapeutic potential of BPC 157 and L-arginine as novel interventions for cyclophosphamide-induced hemorrhagic cystitis. The robust protective effects observed suggest these c…
This research highlights a potentially transformative role for BPC 157 in improving the safety profile of widely used antiplatelet therapies. By mitigating the risk of excessive bleeding, BPC 157 could enable safer an…
This study provides compelling evidence that BPC 157 could be a powerful therapeutic agent for conditions involving severe vascular occlusion and subsequent organ damage, such as Budd-Chiari syndrome. Its ability to p…
The consistent and potent pro-healing effects of BPC 157 across multiple challenging fistula models highlight its significant potential as a novel therapeutic agent. This peptide could offer a non-invasive, effective …
These findings highlight BPC 157's significant potential as a therapeutic agent for preventing and treating NSAID-induced gastrointestinal damage. By simultaneously stabilizing intestinal permeability and enhancing in…
This research highlights the significant therapeutic potential of BPC 157 for preventing or treating hepatic ischemia-reperfusion injury, a common and severe complication in liver surgery and transplantation. Given it…
This research highlights BPC 157's significant potential as a protective agent against lidocaine-induced neurotoxicity, a substantial concern in various clinical settings where local anesthetics are used. The findings…
This research highlights BPC 157's potential as a novel therapeutic agent for neurological conditions characterized by nitric oxide dysregulation, particularly those manifesting as schizophrenia-like symptoms or other…
This study provides compelling evidence that BPC 157 is a highly effective therapeutic agent for preventing and treating post-surgical bowel adhesions. The observed interaction with L-NAME and L-arginine strongly sugg…
This research highlights the significant gastroprotective potential of BPC 157 against drug-induced injury. The ability of BPC 157 to reduce lesion severity, inflammation, and oxidative stress while promoting healing …
This study unveils a novel therapeutic potential for BPC 157 beyond its well-established regenerative and protective properties, specifically in the context of modulating local anesthetic effects. Accelerating recover…
This study provides compelling evidence that BPC 157 possesses significant retinoprotective and neuroprotective properties against ischemia-induced damage. Its ability to preserve both retinal function and structural …
The study revealed significant therapeutic effects of BPC 157 in mitigating the consequences of permanent superior sagittal sinus (SSS) occlusion. Animals treated with BPC 157 exhibited a marked improvement in neurolo…
These findings strongly underscore BPC 157's potent therapeutic potential in accelerating and improving the quality of wound healing. Its multifaceted action, including enhanced collagen synthesis, robust angiogenesis…
This study provides compelling preclinical evidence that BPC 157, administered directly into the joint, possesses broad regenerative and anti-inflammatory properties capable of addressing multiple forms of knee pain a…
This study highlights the significant therapeutic potential of BPC 157 in treating severe vascular occlusive diseases like SMAVO. The ability of BPC 157 to not only reduce tissue damage and inflammation but also to ac…
Free, no account — handy when you're working with BPC-157.